The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up by +0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.20%. December...
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today
The S&P 500 Index ($SPX ) (SPY ) today is up by +0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.06%. December E-mini S&P...
The S&P 500 Index ($SPX ) (SPY ) today is down by -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.49%. December E-mini S&P...
/Vertex%20Pharmaceuticals%2C%20Inc_%20HQ%20in%20Boston-by%20Tada%20Images%20via%20Shuttershock.jpg)
Vertex Pharmaceuticals has underperformed the broader Nasdaq index over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.
Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in Citi’s 2025 Global Healthcare Conference. Charlie Wagner, Chief Operating and Financial Officer,...
CRISPR Therapeutics is the subject of strong buyout speculation after earning FDA approval for a breakthrough gene-editing therapy.
1 Cash-Heavy Stock with Solid Fundamentals and 2 We Ignore
Vertex Pharmaceuticals’ stock has trailed behind the broader market, but analysts are still taking a moderately bullish stance about its prospects.